BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36139038)

  • 1. The Effect of Aggregated Alpha Synuclein on Synaptic and Axonal Proteins in Parkinson's Disease-A Systematic Review.
    Murphy J; McKernan DP
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
    Kawahata I; Finkelstein DI; Fukunaga K
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies.
    Sekigawa A; Takamatsu Y; Sekiyama K; Hashimoto M
    Biomolecules; 2015 May; 5(2):1000-11. PubMed ID: 25996784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.
    Garcia-Reitböck P; Anichtchik O; Bellucci A; Iovino M; Ballini C; Fineberg E; Ghetti B; Della Corte L; Spano P; Tofaris GK; Goedert M; Spillantini MG
    Brain; 2010 Jul; 133(Pt 7):2032-44. PubMed ID: 20534649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH; Nielsen MS; Jakes R; Dotti CG; Goedert M
    J Biol Chem; 1998 Oct; 273(41):26292-4. PubMed ID: 9756856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
    Eyal A; Engelender S
    Cell Cycle; 2006 Sep; 5(18):2082-6. PubMed ID: 16969096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein: the long distance runner.
    George S; Rey NL; Reichenbach N; Steiner JA; Brundin P
    Brain Pathol; 2013 May; 23(3):350-7. PubMed ID: 23587141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H; Sandmann-Keil D; Gai W; Braak E
    Neurosci Lett; 1999 Apr; 265(1):67-9. PubMed ID: 10327208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of α-synuclein on axonal transport.
    Volpicelli-Daley LA
    Neurobiol Dis; 2017 Sep; 105():321-327. PubMed ID: 27956085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
    Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
    Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon.
    Sharrad DF; de Vries E; Brookes SJ
    J Comp Neurol; 2013 Feb; 521(3):657-76. PubMed ID: 22821666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease and α-synuclein expression.
    Devine MJ; Gwinn K; Singleton A; Hardy J
    Mov Disord; 2011 Oct; 26(12):2160-8. PubMed ID: 21887711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis.
    Pérez-Acuña D; Shin SJ; Rhee KH; Kim SJ; Lee SJ
    Mol Brain; 2023 Oct; 16(1):72. PubMed ID: 37848910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.
    Roberts RF; Wade-Martins R; Alegre-Abarrategui J
    Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological roles of α-synuclein in neurological disorders.
    Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
    Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.